Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Meningeal Neoplasms
- Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease
- Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
- Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer
- Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
- Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
- Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
- Pembrolizumab in Patients With Leptomeningeal Disease
- Intrathecal Mafosfamide
- DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
- S9624 Ifosfamide in Treating Patients With Meningeal Tumors
- Phase I Study of Intrathecal Topotecan
- Phase I Study of Intrathecal Mafosfamide